Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 948

1.

Clozapine maintenance therapy in schizophrenia.

Gaszner P, Makkos Z.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):465-9.

PMID:
15093952
2.

The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study.

Miodownik C, Lerner V, Kibari A, Toder D, Cohen H.

J Clin Psychiatry. 2006 Aug;67(8):1204-8.

PMID:
16965197
3.

[Long-term clinical experience with clozapine].

Gelly F, Chambon O, Marie-Cardine M.

Encephale. 1997 Sep-Oct;23(5):385-96. French.

PMID:
9453932
4.

[Ten years of clinical experience with clozapine about 170 patients].

Levoyer D, Martinet JP, Badiche A, Millet B.

Encephale. 2004 May-Jun;30(3):285-95. French.

PMID:
15235527
5.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

6.

Long-term treatment of mood disorders in schizophrenia.

Azorin JM.

Acta Psychiatr Scand Suppl. 1995;388:20-3. Review.

PMID:
7541599
7.

Long-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: a retrospective study in Korean children and adolescents.

Kim Y, Kim BN, Cho SC, Kim JW, Shin MS.

Hum Psychopharmacol. 2008 Dec;23(8):715-22. doi: 10.1002/hup.982.

PMID:
18814190
8.
9.

Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.

Sa AR, Hounie AG, Sampaio AS, Arrais J, Miguel EC, Elkis H.

Compr Psychiatry. 2009 Sep-Oct;50(5):437-42. doi: 10.1016/j.comppsych.2008.11.005. Epub 2009 Jan 15.

PMID:
19683614
10.

[Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].

Lévy-Rueff M, Jurgens A, Lôo H, Olié JP, Amado I.

Encephale. 2008 Oct;34(5):526-33. doi: 10.1016/j.encep.2007.08.008. Epub 2008 Jan 11. French.

PMID:
19068343
11.
12.

Management of schizophrenia.

Marder SR.

J Clin Psychiatry. 1996;57 Suppl 3:9-13; discussion 47. Review.

PMID:
8626371
13.

Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis.

Chouinard G, Vainer JL, Bélanger MC, Turnier L, Beaudry P, Roy JY, Miller R.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Nov;18(7):1129-41.

PMID:
7531355
14.

Combination of clozapine and ziprasidone in treatment-resistant schizophrenia: an open clinical study.

Ziegenbein M, Kropp S, Kuenzel HE.

Clin Neuropharmacol. 2005 Sep-Oct;28(5):220-4.

PMID:
16239761
15.

Treatment-resistant schizophrenia--the role of clozapine.

Meltzer HY.

Curr Med Res Opin. 1997;14(1):1-20. Review.

PMID:
9524789
16.

Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.

Wheeler AJ.

Ann Pharmacother. 2008 Jun;42(6):852-60. doi: 10.1345/aph.1K662. Epub 2008 May 13.

PMID:
18477732
17.

Clinical effects of a randomized switch of patients from clozaril to generic clozapine.

Kluznik JC, Walbek NH, Farnsworth MG, Melstrom K.

J Clin Psychiatry. 2001;62 Suppl 5:14-7; discussion 23-4.

18.

Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.

Gaebel W, Möller HJ, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, Von Wilmsdorff M, Bottlender R, Klingberg S.

Eur Arch Psychiatry Clin Neurosci. 2004 Apr;254(2):129-40.

PMID:
15146342
19.

Clozapine efficacy in tardive dyskinesia in schizophrenic patients.

Bassitt DP, Louzã Neto MR.

Eur Arch Psychiatry Clin Neurosci. 1998;248(4):209-11.

PMID:
9810484
20.

Reduction in hospital stay of chronic schizophrenic patients after long-term clozapine treatment.

Ahn YM, Chang JS, Kim Y, Lee KY, Kim JH, Kim SC, Maeng SJ, Kim YS.

Int Clin Psychopharmacol. 2005 May;20(3):157-61.

PMID:
15812266

Supplemental Content

Support Center